cjc-1295 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-26. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off white powder | Typical lyophilized form |
| Water solubility | Soluble | May need a small organic co-solvent |
| Purity assessment | Chromatographic peak area | Most certificates report a percentage figure |
| Storage temperature | Minus 20 C or lower | Dry, dark, sealed container |
| Identity check | Electrospray mass spectrometry | Compared against theoretical mass |
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
=== Primary structure === Chymopapain's zymogen is made up of a total of 352 residues, and it has a weight of approximately 23.78kDa. Three different regions can be distinguished inside the precursor's chain.
=== Common resins === DEAE-C is commonly commercially available as DE52 and DE53. These resins are prepared preswollen although cellulose exchangers swell in a strong basic environment to increase access to binding sites. DE52 has a pKa of 11.5. The buffering range for diethanolamine is 8.4-8.8, though the range for DEAE-C varies between manufacturers.
Chile: Outgoing president Gabriel Boric condemned the strikes, calling for a peaceful resolution to the crisis and reaffirming Chile's commitment to international law and multilateralism rather than violence and foreign interference. President-elect José Antonio Kast said that the capture of Maduro was "great news for the region". Colombia: President Gustavo Petro called for a meeting of the United Nations Security Council and rejected "the aggression against the sovereignty of Venezuela and of Latin America". It was also reported that Colombia had moved troops to the Colombia-Venezuela border to head off clashes and potential inflow of refugees from Venezuela. On 8 January, thousands of Colombians protested against the intervention and the capture of Maduro, including the city of Cúcuta, near the Venezuelan border. Petro also condemned the death of Yohana Rodríguez, a Colombian citizen and one of the two civilian casualties, issuing harsh words to President Trump and those in Colombia celebrating the attacks. Ecuador: President Daniel Noboa said: "To all the narco Chavista criminals, your time is coming.
Sources: en.wikipedia.org
== Administration == Citalopram is typically taken in one dose, either in the morning or evening. It can be taken with or without food. Its absorption does not increase when taken with food, but doing so can help prevent nausea. Nausea is often caused when the 5-HT3 receptors actively absorb free serotonin, as this receptor is present within the digestive tract.
The country was the second-largest producer of pulp in the world and the eighth-largest producer of paper in 2016. In the footwear industry, Brazil was the fourth-largest producer in 2019. It was also the ninth-largest producer of steel in the world. In 2018, the chemical industry of Brazil was the eighth-largest in the world. Although it was among the five largest world producers in 2013, Brazil's textile industry is very little integrated into world trade. The tertiary sector (trade and services) represented 75.8% of the country's GDP in 2018, according to the IBGE. The service sector was responsible for 60% of GDP and trade for 13%. It covers commerce, transport, education, social and health services, research and development, sports activities, etc. Micro and small businesses represent 30% of the country's GDP. In the commercial sector they represent 53% of the GDP within the activities of the sector.
The team of inventors Edison employed at his laboratories in Menlo Park, New Jersey did, however, develop the first practical light bulb in 1880 (employing a carbonized bamboo filament), shortly prior to Joseph Swan, who invented an even more efficient bulb in 1881 (which used a cellulose filament). Henry Ford did not invent either the automobile or the assembly line. He did improve the assembly line process substantially, sometimes through his own engineering but more often through sponsoring the work of his employees, and he was the main person behind the introduction of the Model T, regarded as the first affordable automobile. Karl Benz (co-founder of Mercedes-Benz) is credited with the invention of the first modern automobile, and the assembly line has existed throughout history. Al Gore never said that he had "invented" the Internet. What Gore actually said was, "During my service in the United States Congress, I took the initiative in creating the Internet", in reference to his political work towards developing the Internet for widespread public use. Gore was the original drafter of the High Performance Computing and Communication Act of 1991, which provided significant funding for supercomputing centers, and this in turn led to upgrades of a major part of the already-existing early 1990s Internet backbone, the NSFNet, and development of NCSA Mosaic, the browser that popularized the World Wide Web.
Sources: en.wikipedia.org
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.
Yes. Degradation proceeds faster once the powder is dissolved, especially at room temperature or after multiple freeze and thaw cycles. Working solutions are often aliquoted to avoid repeated handling. Lyophilized powder held cold and dry retains its properties far longer.
Truncated sequences, oxidized residues and aggregated forms can all elute near the main peak. Reversed phase chromatography resolves many of these species, so the number of peaks is a useful indicator of synthesis quality. A single peak does not by itself prove correct sequence, which is why mass confirmation is paired with it.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.